CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers

BACKGROUND: The biological behaviors, clinical treatment, prognosis of non-muscle-invasive bladder cancers (NMIBCs) and muscle-invasive bladder cancers (MIBCs) are distinct. Accurate staging is pivotal in optimal therapy planning for bladder cancers (BCs). However, it is insufficient for urologists...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huang, Liu, Yu, Cao, Chuanzhen, Xi, Hao, Chen, Wenting, Zheng, Wei, Dong, Xin, Zheng, Shan, Li, Lin, Ma, Jianhui, Gao, Yanning, Shou, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246191/
https://www.ncbi.nlm.nih.gov/pubmed/34268374
http://dx.doi.org/10.21037/atm-19-4511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246191/
https://www.ncbi.nlm.nih.gov/pubmed/34268374
http://dx.doi.org/10.21037/atm-19-4511

Ejemplares similares